Pakistan’s listed pharmaceutical companies started 2026 with stronger financial performance as profits and margins improved during the first quarter of the year.
According to sector data compiled by Topline Securities, the pharmaceutical industry recorded profit after tax of around Rs. 10.19 billion between January and March 2026. This showed an increase of 17% compared to the same period last year.
The sector’s total sales also increased during the quarter, reaching Rs. 90.65 billion. However, gross profits grew at a much faster pace, indicating better margins and improved earnings for pharmaceutical companies after recent policy changes in medicine pricing.
Industry analysts say drug price deregulation has provided companies with additional financial flexibility.
Instead of only strengthening balance sheets, many pharmaceutical firms are now using their improved cash flows to expand their market presence and compete more aggressively.
Reports showed that companies significantly increased spending on marketing and sales activities during the quarter. Selling and distribution expenses rose by 20% compared to last year, reaching Rs. 17.10 billion.
Experts believe this increase reflects growing investment in product promotion, expansion of sales teams, stronger distribution networks, doctor engagement programs, and wider market outreach.
The sector’s gross profit margins also improved, reaching around 43% during the quarter compared to 39% in the same period last year. Analysts say this indicates stronger pricing power and better operational performance across the industry.
The pharmaceutical sector is considered an important part of Pakistan’s manufacturing and healthcare economy.
Rising demand for medicines, expanding healthcare needs, and improved profitability are encouraging companies to focus on growth and competition.
Market experts believe that if economic stability continues and regulatory conditions remain supportive, Pakistan’s pharmaceutical industry could see further expansion in production, investment, and exports in the coming years.